Tracy T Batchelor Selected Research

Tracy T Batchelor Research Topics

Disease

89	Neoplasms (Cancer) 01/2022 - 03/2003
84	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2004
44	Glioma (Gliomas) 01/2022 - 01/2004
18	Lymphoma (Lymphomas) 01/2022 - 03/2003
14	Brain Neoplasms (Brain Tumor) 01/2021 - 04/2009
4	Oligodendroglioma 01/2022 - 03/2005
4	Necrosis 01/2019 - 01/2011
4	Edema (Dropsy) 11/2018 - 01/2007
3	Meningioma (Meningiomas) 01/2022 - 01/2015
3	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2007
3	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2015
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 01/2012
3	Disease Progression 01/2014 - 06/2010
3	Brain Edema (Cerebral Edema) 01/2013 - 04/2009
2	Neurologic Manifestations (Neurological Manifestations) 10/2022 - 01/2019
2	Nervous System Trauma 10/2022 - 01/2018
2	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 12/2006
2	Meningeal Carcinomatosis 08/2020 - 01/2020
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Fatigue 01/2019 - 10/2009
2	Bacterial Infections (Bacterial Infection) 08/2017 - 05/2009
2	Acoustic Neuroma (Acoustic Neurinoma) 09/2010 - 10/2005
2	Hypertension (High Blood Pressure) 10/2009 - 06/2009
2	Pneumonia (Pneumonitis) 05/2009 - 01/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Ependymoma 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 01/2021

Drug/Important Bio-Agent (IBA)

32	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2005
25	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 04/2006
18	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2007
18	cediranib (AZD2171)IBA 01/2017 - 01/2007
12	Pharmaceutical PreparationsIBA 12/2020 - 01/2007
12	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 01/2007
11	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2013
10	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2010
10	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2007
8	alpha-hydroxyglutarateIBA 01/2022 - 09/2013
7	Biological ProductsIBA 01/2022 - 01/2004
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2006
7	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 02/2003
6	Angiogenesis InhibitorsIBA 01/2022 - 12/2007
5	Protons (Proton)IBA 03/2019 - 06/2011
5	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2014
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 11/2005
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2005
5	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2013 - 11/2008
4	TIC10 compoundIBA 11/2020 - 01/2017
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 07/2007
3	Lomustine (CCNU)FDA Link 01/2020 - 09/2013
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2017 - 01/2012
3	Busulfan (Busulfex)FDA Link 12/2017 - 01/2012
3	Phosphotransferases (Kinase)IBA 01/2017 - 04/2006
3	EnzymesIBA 09/2016 - 06/2011
3	CytokinesIBA 01/2016 - 05/2009
3	vandetanib (ZD6474)IBA 08/2015 - 09/2010
3	Thalidomide (Thalomid)FDA Link 01/2009 - 07/2007
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020 - 01/2018
2	Dopamine Receptors (Dopamine Receptor)IBA 11/2020 - 01/2019
2	pembrolizumabIBA 08/2020 - 01/2020
2	epidermal growth factor receptor VIIIIBA 01/2020 - 12/2006
2	dacomitinibIBA 01/2020 - 01/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 01/2019
2	MethyltransferasesIBA 01/2019 - 01/2018
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 10/2017
2	SteroidsIBA 01/2019 - 06/2010
2	Chimeric Antigen ReceptorsIBA 01/2019 - 01/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 05/2009
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2018 - 12/2015
2	CreatineIBA 01/2017 - 06/2011
2	Coenzymes (Enzyme Cofactors)IBA 01/2017 - 12/2015
2	Choline (Choline Chloride)IBA 01/2017 - 06/2011
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2016 - 04/2007
2	CilengitideIBA 10/2015 - 11/2014
2	Oxygen (Dioxygen)IBA 01/2013 - 06/2011
2	Transaminases (Aminotransferases)IBA 06/2011 - 01/2009
2	Endothelial Growth FactorsIBA 05/2010 - 05/2009
2	CollagenIBA 06/2009 - 05/2009
2	Celecoxib (Celebrex)FDA Link 06/2008 - 07/2007
2	Alkylating AgentsIBA 04/2007 - 04/2006
1	Inositol (Myoinositol)IBA 01/2022
1	LipidsIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021
1	palbociclibIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	HexokinaseIBA 12/2020

Therapy/Procedure

67	Therapeutics 10/2022 - 03/2003
28	Drug Therapy (Chemotherapy) 12/2020 - 01/2005
27	Radiotherapy 03/2019 - 03/2005
6	Aftercare (After-Treatment) 01/2022 - 05/2010
5	Immunotherapy 01/2019 - 05/2009
3	Salvage Therapy 01/2020 - 03/2005
3	Stem Cell Transplantation 12/2017 - 01/2012
2	Transplantation 01/2019 - 08/2017
2	Precision Medicine 01/2018 - 04/2016
2	Cranial Irradiation 01/2018 - 08/2015
2	Craniotomy 01/2016 - 05/2009
1	Neurosurgical Procedures 01/2021